ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 8.25
+0.25 (3.13%)
Oct 16, 2026, 2:32 PM CET
ViroGates Market Cap
ViroGates has a market cap or net worth of 76.58 million as of October 16, 2026. It is the 40,987th most valuable company in the world and the 114th biggest in Denmark. Its market cap has decreased by 22.35% in one year.
Market Cap
76.58M
Enterprise Value
62.87M
Revenue
9.36M
Global Rank
Country Rank
#114 Denmark
PE Ratio
n/a
ChartMarket Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 76.58M, a decrease of -70.46%. That is a compound annual growth rate of -13.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 76.58M | -38.66% |
| Dec 30, 2025 | 124.84M | 52.27% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.17T |
| Genmab | 151.12B |
| Coloplast | 105.49B |
| Demant | 75.71B |
| Gubra | 4.76B |
| BioPorto | 522.34M |
| Pharma Equity Group | 86.42M |
| Scandinavian Medical Solutions | 64.79M |